The global Respiratory Pathogen Point-of-Care Analyzer market is gaining strong traction as healthcare systems worldwide prioritize rapid, accurate, and decentralized diagnostic solutions. These analyzers enable near-patient detection of respiratory pathogens, supporting faster clinical decisions and timely treatment initiation in both acute and routine care settings.